Healthcare Services

Adenosine Triphosphate (ATP) Assays Market Global Report 2026 Market Growth Prospects 2026–2030 with Innovation Trends and Competitive Landscape

March 27, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Adenosine Triphosphate (ATP) Assays Market At The End Of The 2026–2030 Forecast Period?

The adenosine triphosphate (atp) assays market has experienced rapid expansion in its size over recent years. This market is projected to expand from $2.19 billion in 2025 to reach $2.45 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 11.6%. Factors contributing to its historical growth include the constrained supply of highly sensitive atp assay kits, the dependence on conventional biochemical assays, an increase in pharmaceutical research endeavors, the expanding acceptance of molecular biology techniques, and the escalating importance of food safety and environmental monitoring.

The adenosine triphosphate (atp) assays market is anticipated to experience significant expansion in the coming years. Its valuation is set to reach $3.88 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.2%. This expansion during the forecast period stems from factors such as the creation of high-throughput atp assay platforms, greater incorporation with automated laboratory equipment, wider usage in clinical diagnostics and personalized medicine, the enlargement of biotechnology research and drug development efforts, and improvements in fluorescent and luminescent assay technologies. Key trends for the upcoming period encompass a growing uptake of atp assays in drug discovery, increased application of cell-based assays for assessing viability and cytotoxicity, broadening use of atp assays in food safety and environmental analysis, an escalating need for luminometric and enzymatic atp assays, and a heightened emphasis on the sensitivity, accuracy, and standardization of these assays.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10767&type=smp

Which Market Drivers Are Supporting The Expansion Of The Adenosine Triphosphate (ATP) Assays Market?

The escalating incidence of cancer, chronic conditions, and infectious diseases is poised to drive the growth of the adenosine triphosphate (ATP) assay market in the coming years. Cancer is characterized by unchecked cell division, capable of invading and damaging adjacent tissues and potentially spreading throughout the body. Chronic diseases represent stable states that typically progress gradually and endure for extended durations. Infectious diseases are caused by disease-causing microorganisms, including bacteria, viruses, fungi, or parasites, which can transmit from one person to another. ATP assays offer a valuable mechanism for diagnosing these illnesses by evaluating cellular viability, detecting microbial presence, assessing the efficacy of treatments, and observing metabolic and mitochondrial dysfunction. As an illustration, the World Health Organization, a Switzerland-based agency of the United Nations, reported in February 2024 that new cancer cases are anticipated to surpass 35 million by 2050, marking a 77% rise from the approximately 20 million cases in 2022. Additionally, figures released in November 2024 by the European Centre for Disease Prevention and Control (ECDC), a Sweden-based European Union agency, revealed 112,883 HIV diagnoses in 2023 across 47 out of 53 countries in the region, with 24,731 cases within the European Union/European Economic Area (EU/EEA). The overall crude HIV diagnosis rate reached 12.7 per 100,000 population, indicating a 2.4% increase from the 12.4 per 100,000 rate observed in 2022. Thus, the rising frequency of cancer, chronic, and infectious diseases acts as a significant impetus for the adenosine triphosphate (ATP) assay market.

What Segment Types Make Up The Adenosine Triphosphate (ATP) Assays Market?

The adenosine triphosphate (atp) assays market covered in this report is segmented –

1) By Type: Luminometric ATP (Adenosine Triphosphate) Assays, Enzymatic ATP (Adenosine Triphosphate) Assays, Bioluminescence Resonance Energy Transfer (BRET) ATP (Adenosine Triphosphate) Assays, Cell-Based ATP (Adenosine Triphosphate) Assays, Other Types

2) By Component: Consumables And Accessories, Instruments

3) By Application: Drug Discovery And Development, Clinical Diagnostics, Environmental Testing, Food Safety And Quality Testing, Other Applications

4) By End User: Pharmaceutical And Biotechnology Companies, Food and Beverage Industry, Hospitals And Diagnostics Laboratories, Academic And Research Institutions

Subsegments:

1) By Luminometric ATP Assays: Luciferase-Based Assays, Chemiluminescent Assays

2) By Enzymatic ATP Assays: Kinase-Based Assays, ATPase Activity Assays

3) By Bioluminescence Resonance Energy Transfer (BRET) ATP Assays: BRET For Protein-Protein Interactions, BRET For Drug Discovery

4) By Cell-Based ATP Assays: Live-Cell ATP Measurement, Cell Viability Assays

5) By Other Types: Fluorescent ATP Assays, Spectrophotometric ATP Assays

Which Market Trends Are Creating New Opportunities In The Adenosine Triphosphate (ATP) Assays Market?

Leading companies within the adenosine triphosphate (ATP) assays market are concentrating on creating technologically advanced kinase testing platforms to deliver highly sensitive assays. A kinase testing platform refers to a specialized system utilized for assessing kinase activity in biological samples, which supports drug discovery and development by offering insights into kinase function and its inhibition. For instance, in April 2024, Reaction Biology, a biotechnology firm based in the US, unveiled the HotSpotTM ATP-Max KinomeScreen. This advanced assay is developed for high-throughput kinase screening, boasting enhanced sensitivity that permits testing at 1 mM ATP levels. This innovative platform employs a gold standard filter binding radiometric assay method to evaluate kinase activity across the most extensive collection of kinase targets in the industry. By furnishing physiologically relevant data, the HotSpotTM ATP-Max KinomeScreen enables researchers to uncover more potent and specific kinase inhibitors, thereby advancing drug discovery initiatives and facilitating the creation of targeted therapies for numerous diseases, particularly cancer.

Who Are The Key Players Driving Competition In The Adenosine Triphosphate (ATP) Assays Market?

Major companies operating in the adenosine triphosphate (atp) assays market are Merck KGaA, Thermo Fisher Scientific Inc., PerkinElmer Inc., Lonza Group, Promega Corporation, Agilent Technologies Inc., Abcam plc, Danaher Corporation, Geno Technology Inc., NEOGEN Corporation, Biomerieux SA, AAT Bioquest Inc., MBL International Corporation, Charm Sciences Inc., Cell Signaling Technology Inc., Cayman Chemical Company, Vazyme Biotech Co. Ltd., SignalChem Lifesciences Corporation, Kaneka Corporation, Novus Biologicals LLC, NANOGEN Biotechnologies Inc., Nacalai Tesque Inc., MoBiTec GmbH, Lumigen Inc., Jena Bioscience GmbH, Goryo Chemical Inc., Cosmo Bio Co. Ltd., BPS Bioscience Inc., BioTek Instruments Inc.

Read the full adenosine triphosphate (atp) assays market report here:

https://www.thebusinessresearchcompany.com/report/adenosine-triphosphate-atp-assays-global-market-report

How Is The Adenosine Triphosphate (ATP) Assays Market Distributed Across Key Geographic Regions?

North America was the largest region in the adenosine triphosphate (ATP) assays market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adenosine triphosphate (atp) assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Adenosine Triphosphate (ATP) Assays Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10767&type=smp

Browse Through More Reports Similar to the Global Adenosine Triphosphate (ATP) Assays Market 2026, By The Business Research Company

protein assays global market report

https://www.thebusinessresearchcompany.com/report/protein-assays-global-market-report

Cell Based Assays Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

in vitro diagnostics enzymes global market report

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-enzymes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795